India · Delayed Price · Currency is INR Ipca Laboratories Statistics
Total Valuation
NSE:IPCALAB has a market cap or net worth of INR 499.42 billion. The enterprise value is 510.15 billion.
| Market Cap | 499.42B |
| Enterprise Value | 510.15B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Aug 7, 2026 |
Share Statistics
NSE:IPCALAB has 253.70 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 253.70M |
| Shares Outstanding | 253.70M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 7.13% |
| Owned by Institutions (%) | 53.15% |
| Float | 139.31M |
Valuation Ratios
The trailing PE ratio is 38.13 and the forward PE ratio is 31.47. NSE:IPCALAB's PEG ratio is 1.43.
| PE Ratio | 38.13 |
| Forward PE | 31.47 |
| PS Ratio | 4.93 |
| PB Ratio | 5.24 |
| P/TBV Ratio | 6.35 |
| P/FCF Ratio | 102.76 |
| P/OCF Ratio | 43.73 |
| PEG Ratio | 1.43 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.41, with an EV/FCF ratio of 104.97.
| EV / Earnings | 38.95 |
| EV / Sales | 5.04 |
| EV / EBITDA | 22.41 |
| EV / EBIT | 27.39 |
| EV / FCF | 104.97 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | 1.66 |
| Interest Coverage | 27.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.53% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.58% |
| Revenue Per Employee | 5.88M |
| Profits Per Employee | 761,069 |
| Employee Count | 17,210 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:IPCALAB has paid 4.34 billion in taxes.
| Income Tax | 4.34B |
| Effective Tax Rate | 24.00% |
Stock Price Statistics
The stock price has increased by +49.60% in the last 52 weeks. The beta is 0.05, so NSE:IPCALAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +49.60% |
| 50-Day Moving Average | 1,845.72 |
| 200-Day Moving Average | 1,594.79 |
| Relative Strength Index (RSI) | 64.19 |
| Average Volume (20 Days) | 619,626 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:IPCALAB had revenue of INR 101.26 billion and earned 13.10 billion in profits. Earnings per share was 51.63.
| Revenue | 101.26B |
| Gross Profit | 68.59B |
| Operating Income | 18.67B |
| Pretax Income | 18.09B |
| Net Income | 13.10B |
| EBITDA | 22.55B |
| EBIT | 18.67B |
| Earnings Per Share (EPS) | 51.63 |
Balance Sheet
The company has 11.96 billion in cash and 8.09 billion in debt, with a net cash position of 3.87 billion or 15.25 per share.
| Cash & Cash Equivalents | 11.96B |
| Total Debt | 8.09B |
| Net Cash | 3.87B |
| Net Cash Per Share | 15.25 |
| Equity (Book Value) | 95.24B |
| Book Value Per Share | 317.84 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 11.42 billion and capital expenditures -6.56 billion, giving a free cash flow of 4.86 billion.
| Operating Cash Flow | 11.42B |
| Capital Expenditures | -6.56B |
| Depreciation & Amortization | 3.88B |
| Net Borrowing | -6.20B |
| Free Cash Flow | 4.86B |
| FCF Per Share | 19.16 |
Margins
Gross margin is 67.73%, with operating and profit margins of 18.44% and 12.93%.
| Gross Margin | 67.73% |
| Operating Margin | 18.44% |
| Pretax Margin | 17.87% |
| Profit Margin | 12.93% |
| EBITDA Margin | 22.27% |
| EBIT Margin | 18.44% |
| FCF Margin | 5.04% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.31%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 0.31% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.32% |
| Earnings Yield | 2.62% |
| FCF Yield | 0.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:IPCALAB is 1,972.28, which is 0.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,972.28 |
| Price Target Difference | 0.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 12.13% |
| EPS Growth Forecast (3Y) | 20.21% |
Stock Splits
The last stock split was on January 10, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jan 10, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |